Vaxil Provides Update on Research Activities

Provided By Globe Newswire

Last update: Mar 7, 2022

Not for distribution by US newswire or in United States

NESS-ZIONA, Israel, March 07, 2022 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company is pleased to provide an update on its research activities.